Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Petra Buettner

Heart Center of Leipzig, Leipzig (Germany)

9 More presentations in this session

Presentation thumbnail

Autoantiboides to muscarinic m2 cholinoceptors in patients with paroxysmal atrial fibrillation

Doctor E. Mironova (Moscow, RU)

Abstract Slides

Presentation thumbnail

Quantitative global proteomics and lysine acetylome analysis of changes in left atrial appendage tissue from valvular heart disease patients with atrial fibrillation

Doctor T. Tu (Changsha, CN)

Abstract Slides

Presentation thumbnail

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Professor G. Tse (Hong Kong, CN)

Presentation thumbnail

CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery

Doctor N. Kazem (Vienna, AT)

Abstract Slides

Presentation thumbnail

Ser96Ala genetic variant of human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation

Doctor M. Amioka (Hiroshima, JP)

Access the full session

Session thumbnail

Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Presentation

Atrial arrhythmias

Congress Session

Basic science and arrhythmia pathophysiology

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources